PARP1 and glioblastoma: This indicates that decreased GBM cell growth cannot be a marker of cell stress-mediated induction of NKG2DL and that there are likely to be subsets of GBM cells that will not induce NKG2DL in response to TMZ and PARP inhibitor treatment.